Related Experiment Videos
Chronic granulomatous disease in pediatric patients: 25 years of experience
P Soler-Palacín1, C Margareto, P Llobet
1Immunology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Insights
Chronic granulomatous disease (CGD) is a rare immune deficiency causing severe bacterial and fungal infections. Early diagnosis via clinical suspicion and flow cytometry is crucial for management and preventing fatal outcomes.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Chronic granulomatous disease (CGD) is a primary immune deficiency affecting phagocyte function, leading to life-threatening bacterial and fungal infections.
- It occurs in approximately 1 in 200,000 newborn infants, with defects in oxygen metabolite production by phagocytes.
Purpose of the Study:
- To review the clinical records of pediatric patients diagnosed with CGD.
- To analyze the clinical manifestations, diagnostic methods, infectious agents, and outcomes in a cohort of CGD patients.
Main Methods:
- Retrospective review of clinical records of 13 pediatric patients diagnosed with CGD between 1980 and 2005.
- Diagnosis was initially established using the nitroblue tetrazolium test and confirmed by flow cytometry and genetic techniques (gp91).
Main Results:
- All 13 patients were male, with a mean age at diagnosis of 36 months.
- Common manifestations included abscesses, pneumonia, osteomyelitis, and sepsis, caused by various bacteria (e.g., Staphylococcus aureus, Serratia, Klebsiella) and fungi (e.g., Aspergillus).
- A total of 88 infections were recorded, with Aspergillus and Staphylococcus species being frequently isolated pathogens. Four deaths occurred due to severe infections and complications.
Conclusions:
- Clinical suspicion supported by flow cytometry is key for diagnosing CGD and identifying carrier relatives.
- Prophylactic measures and medical management are essential to prevent severe infections.
- The effectiveness of Interferon-gamma (IFN-gamma) as a treatment remains controversial.
Introduction:
Chronic granulomatous disease (CGD) is an uncommon primary immune deficiency (affecting 1/200,000 newborn infants) caused by a defect in phagocyte production of oxygen metabolites, and resulting in bacterial infections produced by catalase-positive microorganisms and fungal diseases that occasionally may prove fatal.
Methods:
A review is made of the clinical records of 13 pediatric patients diagnosed with CGD between 1980 and 2005.
Results:
All patients were males. The mean age at diagnosis was 36 months. The clinical manifestations at the time of diagnosis comprised the following: Abscesses or abscessified adenopathies 4/13 (Staphylococcus aureus (2), Serratia liquefaciens, S. marcescens and Klebsiella sp.), pneumonia 3/13 (Rhodococcus equi, Salmonella typhimurium plus Pneumocystis jiroveci), osteomyelitis 1/13 (Aspergillus sp.), sepsis 1/13 (S. aureus), urinary infection 1/13 (Klebsiella sp.), severe gastroenteritis 1/13, oral aphthae 1/13 and Crohn-like inflammatory bowel disease 1/13. The diagnosis was initially established by the nitroblue tetrazolium test, and confirmed by flow cytometry 10/13 and genetic techniques (gp91) 9/13. In the course of these disease processes there were 88 infections: abscesses (n = 26), lymphadenitis (n = 12), pneumoniae (n = 10), gastroenteritis (n = 7), sepsis (n = 6), osteomyelitis (n = 3) and others (n = 24). As to the germs isolated, the frequency distribution was as follows (n = 49): Aspergillus sp. (n = 10), Staphylococcus sp. (n = 7), Salmonella sp. (n = 6), Serratia sp. (n = 5), Pseudomonas aeruginosa (n = 4), Klebsiella sp. (n = 4), Proteus sp. (n = 3), Leishmania sp. (n = 2) and others (n = 8). IFN-gamma was administered in 7/13 cases, and itraconazole in 9/13; all received cotrimoxazole. There were four deaths, with one case each of sepsis due to gramnegative bacterial infection; disseminated aspergillosis; visceral leishmaniasis and hemophagocytosis; and post-kidney transplant complications.
Conclusions:
Clinical suspicion and flow cytometry are the keys for diagnosis of CGD and detection of carrier relatives. Specific prophylactic measures and medical controls are required to prevent serious infections. IFN-gamma has been used intermittently, though its effectiveness is controversial.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cryptococcal Meningitis